Abstract
The intraperitoneal injection of glycogen in the mouse resulted, shortly thereafter, in the accumulation of 14–23 million neutrophils in the peritoneal cavity and a four-fold increase in the numbers of circulating neutrophils. Preceding the influx of leukocytes, the exudation of plasma proteins and the chemotactic activity for mouse neutrophil in vitro increased in the peritoneal fluid. Among various protease inhibitors examined, chymostatin alone suppressed the plasma protein exudation. Indomethacin and dexamethasone reduced the accumulation of white cells and protein exudation. These nonsteroidal and steroidal antiinflammatory drugs were equally effective whether given simultaneously with or 60 min before glycogen or whether administered intraperitoneally or orally. Colchicine showed a suppressive effect on the leukocyte accumulation but enhanced the protein exudation.
Similar content being viewed by others
References
Hirsch, J. G., andA. B. Church. 1960. Studies of phagocytosis of group A streptococci by polymorphonuclear leukocytes in vitro.J. Exp. Med. 111:309–322.
Hirsch, J. G. 1960. Further studies on preparation and properties of phagocytin.J. Exp. Med 111:323–337.
Yamashita, T., N. Imaizumi, andS. Yuasa. 1979. Effect of endocellular cryoprotectant upon polymorphonuclear neutrophil function during storage at low temperature.Cryobiology 16:112–117.
Yamashita, T., K. Takamori, andY. Tanaka. 1979. A possible preferential inhibition of chemotaxis of polymorphonuclear neutrophils by a chemical modification.Experientia 35:1345–1347.
Yamashita, T., Y. Tanaka, andH. Matsuzawa. 1980. Cytoplasmic and plasma membrane adenosine triphosphatase of polymorphonuclear neutrophils. Comparison of their enzymatic properties and attempt for a direct determination of myosin ATPase activity using polymorphonuclear neutrophil extract.Biochim. Biophys. Acta 599:246–253.
Ishibashi, Y., andT. Yamashita. 1981. Generation of a phagocytosis-stimulating factor by polymorphonuclear neutrophils during phagocytosis.Int. Arch. Allergy Appl. Immunol. 64:181–189.
Nagaoka, I., andT. Yamashita. 1981. Inactivation of phagocytosis-stimulating activity of tuftsin by polymorphonuclear neutrophils. A possible role of leucine aminopeptidase as an ecto-enzyme.Biochim. Biophys. Acta 675:85–93.
Snyderman, R., J. K. Phillips, andS. E. Mergenhagen. 1971. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.J. Exp. Med. 134:1131–1143.
Weichselbaum, T. E. 1946. Accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma.Am. J. Clin. Pathol. Tech. Sect. 10:40–49.
Yamashita, T. 1959. Studies on muscle glycogen (I). About the fractions of muscle glycogen of frog.Seikagaku 31:300–309 (in Japanese).
Whittle, B. A. 1964. The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics.Br. J. Pharmacol. 22:246–253.
Hayashi, H. 1975. The intracellular neutral SH-dependent protease associated with inflammatory reactions.Int. Rev. Cytol. 40:101–151.
Movat, H. Z. 1979. Kinins and kinin system as inflammatory mediators.In Chemical Messengers of the Inflammatory Process. J. C. Houck, editor. Elsevier/North-Holland Biomedical Press, Amsterdam. 47–112.
Gleisner, J. M. 1979. Lysosomal factors in inflammation.In Chemical Messengers of the Inflammatory Process. J. C. Houck, editor. Elsevier/North-Holland Biomedical Press, Amsterdam. 229–260.
Moncada, S., S. H. Ferreira, andJ. R. Vane. 1973. Prostaglandins, aspirin-like drugs and the oedema of inflammation.Nature 246:217–219.
Lewis, A. J., D. J. Nelson, andM. F. Sugrue. 1975. On the ability of prostaglandin Ei and arachidonic acid to modulate experimentally induced oedema in the rat paw.Br. J. Pharmacol. 55:51–56.
Williams, T. J., andJ. Morley. 1973. Prostaglandins as potentiators of increased vascular permeability in inflammation.Nature 246:215–217.
Thomas, G., andG. B. West. 1973. Prostaglandins as regulators of bradykinin responses.J. Pharm. Pharmacol. 25:747–748.
Ferreira, S. H. 1979. Prostaglandins.In Chemical Messengers of the Inflammatory Process. J. C. Houck, editor. Elsevier/North-Holland Biomedical Press, Amsterdam. 113–151.
Turner, S. R., J. A. Trainer, andW. S. Lynn. 1975. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets.Nature 257:680–681.
Goetzl, E. J., J. M. Woods, andR. R. Gorman. 1977. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-Lhydroxy-5, 8, 10, 14-eicosatetraenoic acid.J. Clin. Invest. 59:179–183.
Malmsten, C. L., J. Palmblad, A.-M. Udèn, O. Rådmark, L. Engstedt, andB. Samuelsson. 1980. Leukotriene B4: A highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes.Acta Physiol. Scand. 110:449–451.
Goetzl, E. J., andW. C. Pickett. 1980. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).J. Immunol. 125:1789–1791.
Smith, M. J. H., A. W. Ford-Hutchinson, andM. A. Bray. 1980. LeukotrieneB: A potential mediator of inflammation.J. Pharm. Pharmacol. 32:517–518.
Ford-Hutchinson, A. W., M. A. Bray, M. V. Doig, M. E. Shipley, andM. J. H. Smith. 1980. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.Nature 286:264–265.
Goetzl, E. J., A. R. Brash, A. I. Tauber, J. A. Oates, andW. C. Hubbard. 1980. Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids.Immunology 39:491–501.
Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.Nature (London)New Biol. 231:232–235.
Smith, J. B., andA. L. Willis. 1971. Aspirin selectively inhibits prostaglandin production in human platelets.Nature (London),New Biol. 231:235–237.
Ferreira, S. H., S. Moncada, andJ. R. Vane. 1971. Indomethacin and aspirin abolish prostaglandin release from the spleen.Nature (London),New Biol. 231:237–239.
Ferreira, S. H., andJ. R. Vane. 1974. New aspects of the mode of action of nonsteroid antiinflammatory drugs.Annu. Rev. Pharmacol. 14:57–73.
Flower, R. J. 1974. Drugs which inhibit prostaglandin biosynthesis.Pharmacol. Rev. 26:33–67.
Hamberg, M., J. Svensson, andB. Samuelsson. 1974. Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.Proc. Natl. Acad. Sci. U.S.A. 71:3824–3828.
Hamberg, M., andB. Samuelsson. 1974. Prostaglandin endoperoxide. Novel transformations of arachidonic acid in human platelets.Proc. Natl. Acad. Sci. U.S.A. 71:3400–3404.
Roth, G. J., N. Stanford, andP. W. Majerus. 1975. Acetylation of prostaglandin synthetase by aspirin.Proc. Natl. Acad. Sci. U.S.A. 72:3073–3076.
Rome, L. H., W. E. Lands, G. J. Roth, andP. W. Majerus. 1976. Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandins.Prostaglandins 11:23–30.
Gryglewski, R. J., B. Panczenko, R. Korbut, L. Grodzinska, andA. Ocetkiewicz. 1975. Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig.Prostaglandins 10:343–355.
Lewis, G. P., andP. J. Piper. 1975. Inhibition of release of prostaglandins as an explanation of some of the actions of antiinflammatory corticosteroids.Nature 254:308–311.
Kantrowitz, F., D. R. Robinson, andM. B. McGuire. 1975. Corticosteroids inhibit prostaglandin production by rheumatoid synovia.Nature 258:737–739.
Tashjian, A. H., Jr., E. F. Voelkel, J. McDonough, andL. Levine. 1975. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells.Nature 258:739–741.
Floman, Y., andU. Zor. 1976. Mechanism of steroid action in inflammation: Inhibition of prostaglandin synthesis and release.Prostaglandins 12:403–413.
Nijkamp, F. P., R. J. Flower, S. Moncada, andJ. R. Vane. 1976. Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by antiinflammatory steroids.Nature 263:479–482.
Hong, S.-C. L., andL. Levine. 1976. Inhibition of arachidonic acid release from cells as the biochemical action of antiinflammatory corticosteroids.Proc. Natl. Acad. Sci. U.S.A. 73:1730–1734.
Blackwell, G. J., R. J. Flower, F. P. Nijkamp, andJ. R. Vane. 1978. Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation and inhibition by antiinflammatory steroids.Br. J. Pharmacol. 62:79–89.
Tam, S., S.-C. L. Hong, andL. Levine. 1977. Relationships, among the steroids, of antiinflammatory properties and inhibition of prostaglandin production and arachidonic acid release by transformed mouse fibroblasts.J. Pharmac. Exp. Ther. 203:162–168.
Danon, A., andG. Assouline. 1978. Inhibition of prostaglandin biosynthesis by corticosteroids requires RNA and protein synthesis.Nature 273:552–554.
Flower, R. J., andG. J. Blackwell. 1979. Antiinflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation.Nature 278:456–459.
DiRosa, M., andP. Persico. 1979. Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leukocytes.Br. J. Pharmacol. 66:161–163.
Carnuccio, R., M. Dirosa, andP. Persico. 1980. Hydrocortisone-induced inhibitor of prostaglandin biosynthesis in rat leukocytes.Br. J. Pharmacol. 68:14–16.
Tsurufuji, S., K. Sugio, andF. Takemasa. 1979. The role of glucocorticoid receptor and gene expression in the antiinflammatory action of dexamethasone.Nature 280:408–410.
Borel, J. F. 1973. Effect of some drugs on the chemotaxis of rabbit neutrophils in vitro.Experientia 29:676–678.
Rivkin, I., G. V. Foschi, andC. H. Rosen. 1976. Inhibition of in vitro neutrophil chemotaxis and spontaneous motility by antiinflammatory agents.Proc. Soc. Exp. Biol. Med. 153:236–240.
Caner, J. E. Z. 1965. Colchicine inhibition of chemotaxis.Arthritis Rheum. 8:757–760.
Ward, P. A. 1971. Leukotactic factors in health and disease.Am. J. Pathol. 64:521–530.
Bandmann, U., L. Rydgren, andB. Norberg. 1974. The difference between random movement and chemotaxis. Effects of antitubulins on neutrophil granulocyte locomotion.Exp. Cell Res. 88:63–73.
Ramsey, W. S., andA. Harris. 1973. Leucocyte locomotion and its inhibition by antimitotic drugs.Exp. Cell Res. 82:262–270.
Becker, E. L., andH. J. Showell. 1974. The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release.J. Immunol. 112:2055–2062.
Dinarello, C. A., M. J. Chusid, A. S. Fauci, J. I. Gallin, D. C. Dale, andS. M. Wolff. 1976. Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever.Arthritis Rheum. 19:618–622.
Borisy, G. G., andE. W. Taylor. 1967. The mechanism of action of colchicine. Binding of colchicine-3H to cellular protein.J. Cell Biol. 34:525–533.
Borisy, G. G., andE. W. Taylor. 1967. The mechanism of action of colchicine. Colchicine binding to sea urchin eggs and the mitotic apparatus.J. Cell Biol. 34:535–548.
Malawista, S. E., andK. G. Bensch. 1967. Human polymorphonuclear leukocytes: Demonstration of microtubules and effect of colchicine.Science 156:521–522.
Robinson, D. R., andL. Levine. 1974. Prostaglandin concentrations in synovial fluid in rheumatic diseases: Action of indomethacin and aspirin.In Prostaglandin Synthetase Inhibitors. H. J. Robinson and J. R. Vane, editors. Raven Press, New York. 223–228.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamashita, T., Ishibashi, Y., Nagaoka, I. et al. Studies on glycogen-induced inflammation of mice. Inflammation 6, 87–101 (1982). https://doi.org/10.1007/BF00910722
Issue Date:
DOI: https://doi.org/10.1007/BF00910722